Page last updated: 2024-09-05

lenalidomide and Obesity

lenalidomide has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, H; Hu, N; Jiang, S; Jones, KR; Kang, YM; Luo, F; Ren, J; Xiong, L; Zhu, X; Zou, Y1
Dong, M; Hua, Y; Jones, KR; Li, L; Li, Q; Ren, J; Smith, DT; Yuan, M1

Other Studies

2 other study(ies) available for lenalidomide and Obesity

ArticleYear
Tumour necrosis factor-α inhibition with lenalidomide alleviates tissue oxidative injury and apoptosis in ob/ob obese mice.
    Clinical and experimental pharmacology & physiology, 2014, Volume: 41, Issue:7

    Topics: Animals; Apoptosis; Blood Glucose; Gene Expression Regulation; Glucose; Immunologic Factors; Intestine, Small; Kidney; Lenalidomide; Mice; Mice, Obese; Muscle, Skeletal; Obesity; Oxidative Stress; Thalidomide; Tumor Necrosis Factor-alpha

2014
Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice.
    Obesity (Silver Spring, Md.), 2012, Volume: 20, Issue:11

    Topics: Absorptiometry, Photon; Animals; Blotting, Western; Caspases, Effector; Cells, Cultured; Endoplasmic Reticulum; Fas Ligand Protein; Interleukin-6; Lenalidomide; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardial Contraction; Myocytes, Cardiac; Obesity; Signal Transduction; Thalidomide; Tumor Necrosis Factor-alpha

2012